These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20471566)

  • 21. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment.
    Almeida DR; Carvalho AC; Branco JN; Pereira AP; Correa L; Vianna PV; Buffolo E; Martinez EE
    J Heart Lung Transplant; 1996 Oct; 15(10):988-92. PubMed ID: 8913915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].
    Sosa Estani S; Segura EL
    Medicina (B Aires); 1999; 59 Suppl 2():166-70. PubMed ID: 10668259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral trypanosomiasis in a renal transplant recipient.
    Cicora F; Escurra V; Bibolini J; Petroni J; González I; Roberti J
    Transpl Infect Dis; 2014 Oct; 16(5):813-7. PubMed ID: 25040263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.
    Olivieri BP; de Souza AP; Cotta-de-Almeida V; de Castro SL; Araújo-Jorge T
    Exp Parasitol; 2006 Nov; 114(3):228-34. PubMed ID: 16620811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of chronic Chagas' disease. Is the etiological treatment effective?].
    Rassi A; Rassi Júnior A
    Arq Bras Cardiol; 1998 Oct; 71(4):643-6. PubMed ID: 10347944
    [No Abstract]   [Full Text] [Related]  

  • 29. Transmission of Chagas' disease through transplanted kidney: occurrence of the acute form of the disease in two recipients from the same donor.
    Ferraz AS; Figueiredo JF
    Rev Inst Med Trop Sao Paulo; 1993; 35(5):461-3. PubMed ID: 8115816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.
    Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of Trypanosoma cruzi by heart transplantation.
    Kun H; Moore A; Mascola L; Steurer F; Lawrence G; Kubak B; Radhakrishna S; Leiby D; Herron R; Mone T; Hunter R; Kuehnert M;
    Clin Infect Dis; 2009 Jun; 48(11):1534-40. PubMed ID: 19400748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental cardiac transplantation and chronic Chagas' disease in dogs.
    Boullon F; Sinagra A; Riarte A; Lauricella M; Barra J; Besanson M; Lejour C; Lopez Blanco O; Favaloro R; Segura EL
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):432-7. PubMed ID: 3126576
    [No Abstract]   [Full Text] [Related]  

  • 33. [Benzonidazole: one of the rare treatment for Chagas disease].
    Coilliot C; Rouault M; Wolf A; Boulliat C; Beranger C; Gaillard K; Oliver M
    Med Trop (Mars); 2011 Feb; 71(1):25-7. PubMed ID: 21585085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma cruzi myocardial infection reactivation presenting as complete atrioventricular block in a Chagas' heart transplant recipient.
    Bestetti RB; Cury PM; Theodoropoulos TA; Villafanha D
    Cardiovasc Pathol; 2004; 13(6):323-6. PubMed ID: 15556779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chagas disease in the immunosuppressed host.
    Bern C
    Curr Opin Infect Dis; 2012 Aug; 25(4):450-7. PubMed ID: 22614520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi].
    Andrade SG; Figueira RM
    Rev Inst Med Trop Sao Paulo; 1977; 19(5):335-41. PubMed ID: 416483
    [No Abstract]   [Full Text] [Related]  

  • 38. Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole.
    Altclas J; Sinagra A; Jaimovich G; Salgueira C; Luna C; Requejo A; Milovic V; De Rissio A; Feldman L; Riarte A
    Transpl Infect Dis; 1999 Jun; 1(2):135-7. PubMed ID: 11428981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chagas disease after organ transplantation--United States, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):210-2. PubMed ID: 11922190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.